537 related articles for article (PubMed ID: 33967789)
1. Alterations of Cytochrome P450s and UDP-Glucuronosyltransferases in Brain Under Diseases and Their Clinical Significances.
Sheng Y; Yang H; Wu T; Zhu L; Liu L; Liu X
Front Pharmacol; 2021; 12():650027. PubMed ID: 33967789
[TBL] [Abstract][Full Text] [Related]
2. Relation of Transcriptional Factors to the Expression and Activity of Cytochrome P450 and UDP-Glucuronosyltransferases 1A in Human Liver: Co-Expression Network Analysis.
Zhong S; Han W; Hou C; Liu J; Wu L; Liu M; Liang Z; Lin H; Zhou L; Liu S; Tang L
AAPS J; 2017 Jan; 19(1):203-214. PubMed ID: 27681103
[TBL] [Abstract][Full Text] [Related]
3. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
4. The UDP-glucuronosyltransferases of the blood-brain barrier: their role in drug metabolism and detoxication.
Ouzzine M; Gulberti S; Ramalanjaona N; Magdalou J; Fournel-Gigleux S
Front Cell Neurosci; 2014; 8():349. PubMed ID: 25389387
[TBL] [Abstract][Full Text] [Related]
5. Potential metabolism determinants and drug-drug interactions of a natural flavanone bavachinin.
Li X; Xing H; Qin Z; Yang J; Wang P; Zhang X; Yao Z; Yao X
RSC Adv; 2020 Sep; 10(58):35141-35152. PubMed ID: 35515695
[TBL] [Abstract][Full Text] [Related]
6. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions.
Li L; Hu H; Xu S; Zhou Q; Zeng S
Curr Drug Metab; 2012 Jun; 13(5):615-23. PubMed ID: 22475332
[TBL] [Abstract][Full Text] [Related]
7. Protein-protein interactions between rat hepatic cytochromes P450 (P450s) and UDP-glucuronosyltransferases (UGTs): evidence for the functionally active UGT in P450-UGT complex.
Ishii Y; Iwanaga M; Nishimura Y; Takeda S; Ikushiro S; Nagata K; Yamazoe Y; Mackenzie PI; Yamada H
Drug Metab Pharmacokinet; 2007 Oct; 22(5):367-76. PubMed ID: 17965520
[TBL] [Abstract][Full Text] [Related]
8. Expression of UDP-glucuronosyltransferases (UGTs) 2B7 and 1A6 in the human brain and identification of 5-hydroxytryptamine as a substrate.
King CD; Rios GR; Assouline JA; Tephly TR
Arch Biochem Biophys; 1999 May; 365(1):156-62. PubMed ID: 10222050
[TBL] [Abstract][Full Text] [Related]
9. Drug-Metabolizing Activity, Protein and Gene Expression of UDP-Glucuronosyltransferases Are Significantly Altered in Hepatocellular Carcinoma Patients.
Lu L; Zhou J; Shi J; Peng XJ; Qi XX; Wang Y; Li FY; Zhou FY; Liu L; Liu ZQ
PLoS One; 2015; 10(5):e0127524. PubMed ID: 26010150
[TBL] [Abstract][Full Text] [Related]
10. Traditional Herbal Formulas to as Treatments for Musculoskeletal Disorders: Their Inhibitory Effects on the Activities of Human Microsomal Cytochrome P450s and UDP-glucuronosyltransferases.
Jin SE; Seo CS; Shin HK; Ha H
Pharmacogn Mag; 2016; 12(48):241-252. PubMed ID: 27867264
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory and Inductive Effects of
Jeong H; Kim S; Kim MY; Lee J; An BH; Kim HD; Jeong H; Song YS; Chang M
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380747
[No Abstract] [Full Text] [Related]
12. Expression of hepatic cytochrome P450s and UDP-glucuronosyltransferases in PXR and CAR double humanized mice treated with rifampicin.
Lee SY; Lee JY; Kim YM; Kim SK; Oh SJ
Toxicol Lett; 2015 Jun; 235(2):107-15. PubMed ID: 25835148
[TBL] [Abstract][Full Text] [Related]
13. [Drug glucuronidation and disposition in brain].
Zhang ZQ; Sheng L; Li Y
Yao Xue Xue Bao; 2016 Nov; 51(11):1674-80. PubMed ID: 29908109
[TBL] [Abstract][Full Text] [Related]
14. Regulation of Mammalian UDP-Glucuronosyltransferases.
Wang H; Cao G; Wang G; Hao H
Curr Drug Metab; 2018; 19(6):490-501. PubMed ID: 29521218
[TBL] [Abstract][Full Text] [Related]
15. UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: A systematic review of UGT isoforms for precision medicine.
Yang N; Sun R; Liao X; Aa J; Wang G
Pharmacol Res; 2017 Jul; 121():169-183. PubMed ID: 28479371
[TBL] [Abstract][Full Text] [Related]
16. The UDP-glucuronosyltransferases as oligomeric enzymes.
Finel M; Kurkela M
Curr Drug Metab; 2008 Jan; 9(1):70-6. PubMed ID: 18220573
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of cytochrome P450 and uridine 5'-diphospho-glucuronosyltransferases by MAM-2201 in human liver microsomes.
Kong TY; Kim JH; Kwon SS; Cheong JC; Kim HS; In MK; Lee HS
Arch Pharm Res; 2017 Jun; 40(6):727-735. PubMed ID: 28484907
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases.
Navarro-Mabarak C; Camacho-Carranza R; Espinosa-Aguirre JJ
Drug Metab Rev; 2018 May; 50(2):95-108. PubMed ID: 29451034
[TBL] [Abstract][Full Text] [Related]
19. Mutual Influence of Human Cytochrome P450 Enzymes and UDP-Glucuronosyltransferases on Their Respective Activities in Recombinant Fission Yeast.
Sharma SS; Sharma S; Zhao J; Bureik M
Biomedicines; 2023 Jan; 11(2):. PubMed ID: 36830817
[TBL] [Abstract][Full Text] [Related]
20. A dual system platform for drug metabolism: Nalbuphine as a model compound.
Liang RJ; Shih YN; Chen YL; Liu WY; Yang WL; Lee SY; Wang HJ
Eur J Pharm Sci; 2020 Jan; 141():105093. PubMed ID: 31648049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
